Syneos Health Extends Partnership with Medable


Partnership started in April 2021 will continue to advance clinical trials through DCT solutions.

Syneos Health announced it has extended its strategic partnership with Medable. Syneos Health first partnered with Medable in April 2021. Over the past 18 months, Syneos Health and Medable have collaborated on more than 15 clinical trials with the aim of reaching 21,000 patients across multiple therapeutic areas. Extended work will continue to deliver DCT solutions to address customers’ customized needs.

Read more about the partnership here.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.